Kyle Kolaja, based in Montclair, New Jersey, United States, is currently a Scientific Vice President at Bristol Myers Squibb, bringing experience from previous roles at Bristol Myers Squibb, Celgene, Cellular Dynamics and Kolaja Consulting. Kyle Kolaja holds a 1996 - 1998 post-doctoral fellowship in Toxicology @ University of Kansas Medical Center. With a robust skill set that includes Biomarker Discovery, Cell Culture, Validation, Cell Biology, Project Management and more, Kyle Kolaja contributes valuable insights to the industry. Kyle Kolaja has 1 email and 1 mobile phone number on RocketReach.